dalteparin has been researched along with Glomerulosclerosis, Focal Segmental in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Glomerulosclerosis, Focal Segmental: A clinicopathological syndrome or diagnostic term for a type of glomerular injury that has multiple causes, primary or secondary. Clinical features include PROTEINURIA, reduced GLOMERULAR FILTRATION RATE, and EDEMA. Kidney biopsy initially indicates focal segmental glomerular consolidation (hyalinosis) or scarring which can progress to globally sclerotic glomeruli leading to eventual KIDNEY FAILURE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, W | 1 |
| Chen, X | 1 |
| Ye, Y | 1 |
1 other study available for dalteparin and Glomerulosclerosis, Focal Segmental
| Article | Year |
|---|---|
[Study on mechanism of Shenle and Fragmin in preventing and treating glomerulosclerosis in rats].
Topics: Animals; Collagen; Dalteparin; Drugs, Chinese Herbal; Female; Glomerulosclerosis, Focal Segmental; H | 2000 |